Sakamoto H, Yokoyama N, Nishimoto T, Murai K, Tatsumi H, Kohno S, Ohata K
Department of Pharmacology, Kyoto Pharmaceutical University, Japan.
Jpn J Pharmacol. 1987 Sep;45(1):27-36. doi: 10.1254/jjp.45.27.
The binding characteristics of [3H]quinupramine to rat brain membrane fractions were studied. The specific binding of [3H]quinupramine to rat brain membrane fractions was stable, reversible and saturable. Scatchard analysis of the data from saturation experiments indicated that the specific binding was a single population with an affinity (KD) of 3.04 nM, a maximal binding site number (Bmax) of 714 fmol/mg protein, and a Hill coefficient (nH) of 1.08. Compounds known to inhibit muscarinic cholinergic receptors such as atropine and quinuclidinyl benzilate were the most potent competitors of [3H]quinupramine binding. When the drug potencies in inhibiting [3H]quinupramine binding were tested in the presence of 10 nM atropine, mianserin was the most potent competitor. Studies of the subcellular fractions showed that there was an enrichment of [3H]quinupramine binding sites in the synaptosome fraction. The regional distribution study revealed the highest densities of binding sites in the cerebral cortex and the lowest in the cerebellum. Thus, the specific binding of [3H]quinupramine observed here can be accounted for by both muscarinic cholinergic and serotonin S2 receptors.
研究了[³H]喹硫平与大鼠脑膜组分的结合特性。[³H]喹硫平与大鼠脑膜组分的特异性结合是稳定、可逆且可饱和的。对饱和实验数据进行Scatchard分析表明,特异性结合为单一群体,亲和力(KD)为3.04 nM,最大结合位点数(Bmax)为714 fmol/mg蛋白质,希尔系数(nH)为1.08。已知抑制毒蕈碱型胆碱能受体的化合物,如阿托品和苄基奎宁环酯,是[³H]喹硫平结合的最有效竞争者。当在10 nM阿托品存在下测试药物抑制[³H]喹硫平结合的效力时,米安色林是最有效的竞争者。亚细胞组分研究表明,突触体组分中[³H]喹硫平结合位点富集。区域分布研究显示,大脑皮层中结合位点密度最高,小脑最低。因此,此处观察到的[³H]喹硫平特异性结合可由毒蕈碱型胆碱能受体和5-羟色胺S2受体共同解释。